Scarica l'app Stockscreener
84.23
0.26%
0.22
Dopo l'orario di chiusura:
84.28
0.05
+0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$84.01
Aprire:
$84.16
Volume 24 ore:
955.24K
Relative Volume:
0.72
Capitalizzazione di mercato:
$9.39B
Reddito:
$13.38B
Utile/perdita netta:
$418.00M
Rapporto P/E:
25.44
EPS:
3.3112
Flusso di cassa netto:
$391.00M
1 W Prestazione:
+0.00%
1M Prestazione:
-4.67%
6M Prestazione:
+11.80%
1 anno Prestazione:
+33.34%
Intervallo 1D:
$83.89
$84.92
Intervallo di 1 settimana:
$79.37
$86.40
Portata 52W:
$61.95
$92.18
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
84.23 | 9.39B | 13.38B | 418.00M | 391.00M | 3.3112 |
MCK
Mckesson Corp
|
955.76 | 111.43B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
325.06 | 62.03B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
238.08 | 55.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
AHG
Akso Health Group Adr
|
1.37 | 1.17B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-07-09 | Iniziato | BMO Capital Markets | Market Perform |
| 2026-06-11 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2026-04-16 | Iniziato | BTIG Research | Neutral |
| 2026-04-15 | Iniziato | Citigroup | Buy |
| 2026-02-23 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-08-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Downgrade | Stifel | Buy → Hold |
| 2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
| 2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-01-31 | Iniziato | Morgan Stanley | Underweight |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Ripresa | Credit Suisse | Neutral |
| 2021-02-08 | Ripresa | Piper Sandler | Overweight |
| 2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-01-17 | Iniziato | UBS | Sell |
| 2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Reiterato | Barrington Research | Outperform |
| 2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
| 2018-10-19 | Ripresa | Goldman | Neutral |
| 2018-10-04 | Reiterato | Robert W. Baird | Outperform |
| 2018-08-07 | Reiterato | Stifel | Hold |
| 2018-04-24 | Downgrade | Goldman | Buy → Neutral |
| 2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
Why is Henry Schein stock sliding today? - Investing.com
Henry Schein, Inc. Announces CFO Changes, Effective November 4, 2026 - marketscreener.com
Henry Schein names Emmanuel Caprais CFO: what it means for Henry Schein stock - AD HOC NEWS
Henry Schein (HSIC) Announces CFO Transition: Emmanuel Caprais t - GuruFocus
Henry Schein names new CFO - HME News
Henry Schein names Emmanuel Caprais as new CFO - Investing.com
Henry Schein Appoints Emmanuel Caprais as CFO Effective November 2026 - Kalkine Media
Henry Schein names former ITT executive as new CFO - StreetInsider
Henry Schein Announces Chief Financial Officer Leadership Transition - Business Wire
Henry Schein stock fell 1.39 percent as analysts set USD 110 target - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Henry Schein, Inc. (HSIC) Options Chain - Yahoo! Finance Canada
HSIC or MMSI: Which Is the Better Value Stock Right Now? - Zacks Investment Research
Henry Schein Celebrates 20 Years of Practice Pink - Dentistry Today
Should Value Investors Buy Henry Schein (HSIC) Stock? - Zacks Investment Research
Should Value Investors Buy Henry Schein (HSIC) Stock? - Yahoo Finance
Henry Schein Marks 20th Anniversary of Practice Pink Initiative - Orthodontic Products
Henry Schein expands credit line while analysts rate Henry Schein stock Moderate Buy - AD HOC NEWS
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein Cares Marks 25 Years of Helping Health Happen® - Eagle-Tribune
Henry Schein Cares Marks 25 Years of Helping Health Happen® - Business Wire
Henry Schein Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Henry Schein (HSIC): Buy, Sell, or Hold Post Q2 Earnings? - Yahoo Finance
Henry Schein stock reflects raised 2026 guidance at USD 86.37 - AD HOC NEWS
Ex-Henry Schein manager gets jail for major embezzlement - DrBicuspid.com
Henry Schein Inc Lobbying Profile, 2011 - OpenSecrets
Henry Schein credit supervisor sentenced to prison for embezzling $1.6M from Melville company - Newsday
Henry Schein Q2FY26 Results: Non-GAAP EPS up 15.5%, guidance raised - scanx.trade
Transcript: Henry Schein Q2 2026 Earnings Conference Call - Benzinga
Is Henry Schein Stock Outperforming the Dow? - finance.yahoo.com
Is Henry Schein Stock Outperforming the Dow? - inkl
Henry Schein stock trades below its yearly high after Q2 figures - AD HOC NEWS
Henry Schein stock heads into the open after closing at USD 85.05 - AD HOC NEWS
Henry Schein stock trades at USD 85.56 after Q2 guidance - AD HOC NEWS
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Henry Schein stock gains 0.42 percent ahead of the open - AD HOC NEWS
Henry Schein, Inc. Amends and Restates $1 Billion Revolving Credit Agreement to Increase Commitments to $1.25 Billion - marketscreener.com
Henry Schein Expands Revolving Credit Facility to $1.25 Billion, Extends Maturity to 2031 - TradingView
Henry Schein, Inc. (HSIC) Stock Analysis: A Promising 15.73% Upside in the Healthcare Sector - DirectorsTalk Interviews
Henry Schein Still Gives Me A Reason To Smile After This Nice Move Higher (NASDAQ:HSIC) - Seeking Alpha
Henry Schein (HSIC) Q1 2026 Earnings Call Transcript - Fortune
Henry Schein Prepares to Report Q2 Earnings: What's in the Cards? - Eastern Progress
Are Investors Undervaluing Henry Schein (HSIC) Right Now? - Yahoo Finance
What Makes Henry Schein (HSIC) a New Buy Stock - Yahoo Finance
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring an 11.12% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Henry Schein Inc Share PriceHSIC, RNS News, Articles, Quotes, & Charts (NASDAQ:HSIC) - Proactive financial news
Henry Schein stock holds firm after a fresh target lift - ad-hoc-news.de
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Henry Schein Inc Azioni (HSIC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| HERRING JOSEPH L | Former Director |
Jun 30 '26 |
Proposed Sale |
84.29 |
28,791 |
2,426,793 |
0 |
| Stanley M. Bergman | Affiliate |
Jun 16 '26 |
Proposed Sale |
81.09 |
16,933 |
1,373,097 |
0 |
| DANIEL WILLIAM K | Director |
May 11 '26 |
Buy |
69.19 |
10,000 |
691,900 |
20,000 |
| Popeck Thomas C | CEO, Henry Schein Products |
Mar 19 '26 |
Sale |
72.79 |
1,355 |
98,630 |
86,182 |
| Popeck Thomas C | Officer |
Mar 19 '26 |
Proposed Sale |
72.79 |
1,355 |
98,630 |
0 |
| KUEHN KURT P | Director |
Mar 10 '26 |
Proposed Sale |
78.96 |
2,844 |
224,565 |
0 |
| KUEHN KURT P | Director |
Mar 10 '26 |
Sale |
78.96 |
2,844 |
224,565 |
15,420 |
| LASKAWY PHILIP A | Director |
Mar 05 '26 |
Proposed Sale |
80.36 |
2,844 |
228,544 |
0 |
| LASKAWY PHILIP A | Director |
Mar 05 '26 |
Sale |
80.36 |
2,844 |
228,544 |
21,961 |
| MLOTEK MARK E | Officer |
Mar 04 '26 |
Proposed Sale |
80.80 |
5,925 |
478,739 |
0 |
9.60%
8.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):